From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionModerate evidence
What is happening. St. John's Wort and rifampin are both strong induction concerns for drug-metabolizing enzymes and transporters; the main danger is failure of other concomitant drugs, not loss of rifampin exposure.
Mechanism. Both agents can induce CYP3A4 and P-glycoprotein pathways, creating additive risk for reduced exposure of susceptible third-party medications.
Recommendation. Avoid combining unless the full medication list has been reviewed; monitor or adjust affected concomitant drugs such as anticoagulants, antiretrovirals, transplant drugs, hormonal contraceptives, and azole antifungals.
Stack Score
How it moves the number.
Effect on the composite score
If both Rifampin and St. John's Wort are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009.Needs sourceNo link